Dalan Animal Health startup raises $1.9m seed funding for development of a breakthrough honeybee vaccine
Dalan Animal Health, Inc., a biotech company developing vaccines for new age production animals, announced it has closed funding for a $1.9 million seed round.
This funding accelerates the company's development and commercial activities for the launch of a breakthrough honeybee vaccine targeting American Foulbrood, a highly contagious disease threatening beehives worldwide.
Annette Kleiser, CEO, Dalan: "The company recently completed safety and efficacy testing on its first product and will submit a license application for the conditional approval of the vaccine this fall. It's very exciting to have strong support of our investors on this innovative vaccine. This is not only an innovation for animal health but an important step in saving bees and providing a more sustainable food supply."
Dalan expects to raise a larger round of funding in 2022 to expand their commercial offering and further advance a pipeline of novel vaccines for other new production animals.